Literature DB >> 10957729

Presence of diverse human immunodeficiency virus type 1 viral variants in Cameroon.

P N Fonjungo1, E N Mpoudi, J N Torimiro, G A Alemnji, L T Eno, J N Nkengasong, F Gao, M Rayfield, T M Folks, D Pieniazek, R B Lal.   

Abstract

Phylogenetic analysis of the gp41 region of 123 HIV-1-seropositive specimens from Cameroon showed that 89 were subtype A (71% of these sequences were IbNg-like), 12 (10%) were subtype D, 11 (9%) were subtype G, 5 (4%; closely related to subtype F2) were subtype F, 1 was subtype H, 2 (1.6%) remained unclassifiable, while 3 were group O. Further analysis of the two unclassifiable specimens in gag(p24), pol(prot), and env (C2V3 or gp41) showed that one (98CM19) was a complex mosaic between subtype A in p24 and subtype J prot, and unclassifiable in env (C2V3 or gp41). The second, 98CM63, clustered distinctly from all known subtypes in p24, prot, C2V3, or gp41. 98CM63 clustered with a specimen from Cyprus and these two geographically and epidemiologically unlinked specimens, with their distinct clustering pattern, may represent a new subcluster of subtype A. In conclusion, these findings confirm the high HIV-1 genetic variability and further suggest the continuous appearance of new viral strains in this population.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10957729     DOI: 10.1089/08892220050117087

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  12 in total

Review 1.  TB and HIV in the Central African region: current knowledge and knowledge gaps.

Authors:  S Janssen; M A M Huson; S Bélard; S Stolp; N Kapata; M Bates; M van Vugt; M P Grobusch
Journal:  Infection       Date:  2013-12-06       Impact factor: 3.553

2.  Induction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccine.

Authors:  Deborah Heydenburg Fuller; Premeela A Rajakumar; Lawrence A Wilson; Anita M Trichel; James T Fuller; Tim Shipley; Mary S Wu; Kathleen Weis; Charles R Rinaldo; Joel R Haynes; Michael Murphey-Corb
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  Human immunodeficiency virus type 1 group m protease in cameroon: genetic diversity and protease inhibitor mutational features.

Authors:  Peter N Fonjungo; Eitel N Mpoudi; Judith N Torimiro; George A Alemnji; Laura T Eno; Esther J Lyonga; John N Nkengasong; Renu B Lal; Mark Rayfield; Marcia L Kalish; Thomas M Folks; Danuta Pieniazek
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

4.  Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine design.

Authors:  V Novitsky; N Rybak; M F McLane; P Gilbert; P Chigwedere; I Klein; S Gaolekwe; S Y Chang; T Peter; I Thior; T Ndung'u; F Vannberg; B T Foley; R Marlink; T H Lee; M Essex
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

5.  The role of recombination in the emergence of a complex and dynamic HIV epidemic.

Authors:  Ming Zhang; Brian Foley; Anne-Kathrin Schultz; Jennifer P Macke; Ingo Bulla; Mario Stanke; Burkhard Morgenstern; Bette Korber; Thomas Leitner
Journal:  Retrovirology       Date:  2010-03-23       Impact factor: 4.602

6.  The Evolution of HIV-1 Diversity in Rural Cameroon and its Implications in Vaccine Design and Trials.

Authors:  Rebecca Powell; Denis Barengolts; Luzia Mayr; Phillipe Nyambi
Journal:  Viruses       Date:  2010-02-12       Impact factor: 5.048

7.  Recombination confounds the early evolutionary history of human immunodeficiency virus type 1: subtype G is a circulating recombinant form.

Authors:  Ana B Abecasis; Philippe Lemey; Nicole Vidal; Túlio de Oliveira; Martine Peeters; Ricardo Camacho; Beth Shapiro; Andrew Rambaut; Anne-Mieke Vandamme
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

8.  The evolution of HIV-1 group M genetic variability in Southern Cameroon is characterized by several emerging recombinant forms of CRF02_AG and viruses with drug resistance mutations.

Authors:  Lucy Agyingi; Luzia M Mayr; Thompson Kinge; George Enow Orock; Johnson Ngai; Bladine Asaah; Mbida Mpoame; Indira Hewlett; Phillipe Nyambi
Journal:  J Med Virol       Date:  2013-11-19       Impact factor: 2.327

Review 9.  Evolution and diversity of HIV-1 in Africa--a review.

Authors:  Maria A Papathanasopoulos; Gillian M Hunt; Caroline T Tiemessen
Journal:  Virus Genes       Date:  2003       Impact factor: 2.332

10.  Identification of new, emerging HIV-1 unique recombinant forms and drug resistant viruses circulating in Cameroon.

Authors:  Viswanath Ragupathy; Jiangqin Zhao; Owen Wood; Shixing Tang; Sherwin Lee; Phillipe Nyambi; Indira Hewlett
Journal:  Virol J       Date:  2011-04-23       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.